Literature DB >> 34483674

Illness Acceptance as the Measure of the Quality of Life in Moderate Psoriasis.

Barbara Jankowiak1, Beata Kowalewska1, Elżbieta Krajewska-Kułak1, Rafał Milewski2, Maria Anna Turosz3.   

Abstract

INTRODUCTION: Psoriasis is a chronic disease with intermittent flares and remissions. Each individual perceives the disease, its somatic effects, resultant dysfunction and related problems differently. This attitude is primarily determined by one's characterological traits and type of illness. A primary response to the diagnosis can be denial, underestimation, acceptance or overestimation of the disease. The aim of the study was to analyze the level of illness acceptance and its effect on the quality of life in moderate psoriasis depending on sociodemographic and clinical characteristics of the patients.
MATERIALS AND METHODS: The study included 186 patients with plaque psoriasis with Psoriasis Area Severity Index (PASI) scores ≤10. The inclusion criteria of the study were duration of psoriasis >2 years, age ≥18 years, and lack of other somatic or mental disorders during three months preceding the study. The study participants completed the Acceptance of Illness Scale (AIS), Dermatology Life Quality Index (DLQI) as well as an original survey containing questions about their sociodemographic characteristics and information about their disease.
RESULTS: Mean AIS score for the study group was 24.3 pts. Patients older than 40 years presented with lower levels of illness acceptance than younger persons (p = 0.0311). Also, patients' sex and duration of psoriasis significantly affected the acceptance of the illness, with lower AIS scores found in women (p = 0.0092) and persons with a longer history of the disease (p = 0.0362). Mean DLQI score for the study group was 13.3 pts. A lower level of illness acceptance turned out to exert an unfavorable effect on the quality of life (QOL) in psoriasis (p = 0.0015; R = -0.33).
CONCLUSION: In this study, patients with psoriasis presented with a moderate level of the illness acceptance, and a significant correlation was found between this parameter and QOL.
© 2021 Jankowiak et al.

Entities:  

Keywords:  illness acceptance; psoriasis; psychodermatology; quality of life

Year:  2021        PMID: 34483674      PMCID: PMC8409783          DOI: 10.2147/CCID.S318603

Source DB:  PubMed          Journal:  Clin Cosmet Investig Dermatol        ISSN: 1178-7015


  37 in total

Review 1.  Psoriasis--epidemiology and clinical spectrum.

Authors:  E Christophers
Journal:  Clin Exp Dermatol       Date:  2001-06       Impact factor: 3.470

2.  Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis.

Authors:  Francesca Sampogna; Francesco Sera; Eva Mazzotti; Paolo Pasquini; Angelo Picardi; Damiano Abeni
Journal:  Arch Dermatol       Date:  2003-03

3.  The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients.

Authors:  H Devrimci-Ozguven; T N Kundakci; H Kumbasar; A Boyvat
Journal:  J Eur Acad Dermatol Venereol       Date:  2000-07       Impact factor: 6.166

4.  Acceptance of chronic illness in psoriasis vulgaris patients.

Authors:  A Zalewska; J Miniszewska; J Chodkiewicz; J Narbutt
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-02       Impact factor: 6.166

5.  The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

Authors:  G Krueger; J Koo; M Lebwohl; A Menter; R S Stern; T Rolstad
Journal:  Arch Dermatol       Date:  2001-03

6.  Patients with psoriasis feel stigmatized.

Authors:  Ewa Hrehorów; Joanna Salomon; Lukasz Matusiak; Adam Reich; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

Review 7.  Psychosocial effect of common skin diseases.

Authors:  Benjamin Barankin; Joel DeKoven
Journal:  Can Fam Physician       Date:  2002-04       Impact factor: 3.275

8.  Effects of psychologic intervention on psoriasis: a preliminary report.

Authors:  R Zachariae; H Oster; P Bjerring; K Kragballe
Journal:  J Am Acad Dermatol       Date:  1996-06       Impact factor: 11.527

9.  Recognition of depressive and anxiety disorders in dermatological outpatients.

Authors:  Angelo Picardi; Paolo Amerio; Giannandrea Baliva; Claudio Barbieri; Patrizia Teofoli; Simone Bolli; Valentina Salvatori; Eva Mazzotti; Paolo Pasquini; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

10.  Marriage, impairment, and acceptance in persons with multiple sclerosis.

Authors:  Tracie Harrison; Alexa Stuifbergen; Eishi Adachi; Heather Becker
Journal:  West J Nurs Res       Date:  2004-04       Impact factor: 1.967

View more
  1 in total

1.  Level of Acceptance of Illness and Its Association with Quality of Life among Patients with Epilepsy in North Shewa, Ethiopia.

Authors:  Yonas Teshome; Yerukneh Solomon; Feredegn Talargia; Negese Worku; Abreham Shitaw; Abebaye Aragaw Leminie
Journal:  Behav Neurol       Date:  2022-09-12       Impact factor: 3.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.